BlackRock Health Sciences Trust II (NYSE:BMEZ) Shares Sold by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. lessened its holdings in BlackRock Health Sciences Trust II (NYSE:BMEZGet Rating) by 2.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 35,577 shares of the company’s stock after selling 1,066 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in BlackRock Health Sciences Trust II were worth $585,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the business. Global Retirement Partners LLC boosted its holdings in BlackRock Health Sciences Trust II by 10.2% in the second quarter. Global Retirement Partners LLC now owns 9,635 shares of the company’s stock worth $158,000 after acquiring an additional 895 shares in the last quarter. Commonwealth Equity Services LLC boosted its holdings in BlackRock Health Sciences Trust II by 2.3% in the first quarter. Commonwealth Equity Services LLC now owns 52,979 shares of the company’s stock worth $1,062,000 after acquiring an additional 1,171 shares in the last quarter. Vestmark Advisory Solutions Inc. boosted its holdings in BlackRock Health Sciences Trust II by 2.5% in the second quarter. Vestmark Advisory Solutions Inc. now owns 67,816 shares of the company’s stock worth $1,114,000 after acquiring an additional 1,676 shares in the last quarter. Hollencrest Capital Management boosted its holdings in BlackRock Health Sciences Trust II by 2.2% in the second quarter. Hollencrest Capital Management now owns 93,946 shares of the company’s stock worth $1,544,000 after acquiring an additional 2,034 shares in the last quarter. Finally, Cambridge Investment Research Advisors Inc. lifted its holdings in shares of BlackRock Health Sciences Trust II by 8.8% during the second quarter. Cambridge Investment Research Advisors Inc. now owns 25,549 shares of the company’s stock worth $420,000 after purchasing an additional 2,069 shares during the period.

BlackRock Health Sciences Trust II Stock Down 1.0 %

BlackRock Health Sciences Trust II stock opened at 15.51 on Wednesday. BlackRock Health Sciences Trust II has a 52 week low of 14.33 and a 52 week high of 26.98. The stock has a 50-day moving average price of 15.40 and a 200 day moving average price of 16.17.

BlackRock Health Sciences Trust II Announces Dividend

The company also recently announced a monthly dividend, which will be paid on Friday, December 30th. Investors of record on Friday, December 16th will be issued a dividend of $0.145 per share. This represents a $1.74 dividend on an annualized basis and a dividend yield of 11.22%. The ex-dividend date of this dividend is Thursday, December 15th.

BlackRock Health Sciences Trust II Company Profile

(Get Rating)

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.

Recommended Stories

Institutional Ownership by Quarter for BlackRock Health Sciences Trust II (NYSE:BMEZ)

Receive News & Ratings for BlackRock Health Sciences Trust II Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust II and related companies with MarketBeat.com's FREE daily email newsletter.